Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Turning cold tumors into hot tumors by improving T-cell infiltration
Yuan‐Tong Liu, Zhi‐Jun Sun
Theranostics (2021) Vol. 11, Iss. 11, pp. 5365-5386
Open Access | Times Cited: 519

Showing 1-25 of 519 citing articles:

Nanomaterials for cancer therapy: current progress and perspectives
Zhe Cheng, Maoyu Li, Raja Dey, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 823
Nanoparticles for Cancer Therapy: Current Progress and Challenges
Shreelaxmi Gavas, Sameer Quazi, Tomasz M. Karpiński
Nanoscale Research Letters (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 643
Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research
Xuhui Tong, Rong Tang, Mingming Xiao, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 457
Bioengineered nanogels for cancer immunotherapy
Xianbin Ma, Shu‐Jin Li, Yuantong Liu, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 12, pp. 5136-5174
Closed Access | Times Cited: 126
Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy
Bhalchandra Mirlekar
SAGE Open Medicine (2022) Vol. 10
Open Access | Times Cited: 123
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 114
Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 112
Precision treatment in advanced hepatocellular carcinoma
Xupeng Yang, Chen Yang, Shu Zhang, et al.
Cancer Cell (2024) Vol. 42, Iss. 2, pp. 180-197
Open Access | Times Cited: 112
Extracellular Vesicles: New Classification and Tumor Immunosuppression
Mona Sheta, Eman A. Taha, Yanyin Lu, et al.
Biology (2023) Vol. 12, Iss. 1, pp. 110-110
Open Access | Times Cited: 106
Hot and cold tumors: Immunological features and the therapeutic strategies
Lianjie Wang, Hui Geng, Yujie Liu, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 95
Chronic inflammation, cancer development and immunotherapy
Yalei Wen, Ying‐Jie Zhu, Caishi Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 93
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Lisa H. Butterfield, Yana G. Najjar
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 399-416
Closed Access | Times Cited: 89
Breast Cancer Stem-Like Cells in Drug Resistance: A Review of Mechanisms and Novel Therapeutic Strategies to Overcome Drug Resistance
Taniya Saha, Kiven Erique Lukong
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 75
Reprogramming the immunosuppressive tumor microenvironment through nanomedicine: an immunometabolism perspective
Jieyu Liu, Yinan Bai, Yinggang Li, et al.
EBioMedicine (2024) Vol. 107, pp. 105301-105301
Open Access | Times Cited: 73
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Hydrogel drug delivery systems for minimally invasive local immunotherapy of cancer
Andrew S. Mikhail, Robert Morhard, Michal Mauda‐Havakuk, et al.
Advanced Drug Delivery Reviews (2023) Vol. 202, pp. 115083-115083
Open Access | Times Cited: 57
Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment
Huanhuan Fan, Zijian Guo
Coordination Chemistry Reviews (2023) Vol. 480, pp. 215027-215027
Closed Access | Times Cited: 53
Immune-checkpoint inhibitor resistance in cancer treatment: Current progress and future directions
Chenyue Zhang, Chenxing Zhang, Haiyong Wang
Cancer Letters (2023) Vol. 562, pp. 216182-216182
Closed Access | Times Cited: 53
Immunologic tumor microenvironment modulators for turning cold tumors hot
Gholamreza Khosravi, Samaneh Mostafavi, Sanaz Bastan, et al.
Cancer Communications (2024) Vol. 44, Iss. 5, pp. 521-553
Open Access | Times Cited: 47
Tumor immunotherapy resistance: Revealing the mechanism of PD-1 / PD-L1-mediated tumor immune escape
Jiawen Cui, Yao Li, Yang Yang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116203-116203
Open Access | Times Cited: 35
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 34
Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses
Zhenyu Cao, Jinfeng Zhu, Zicheng Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 24
The crosstalk of CD8+ T cells and ferroptosis in cancer
Zhengjun Lin, Songzhu Zou, Kunming Wen
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 22
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 16
Dual‐Responsive Supramolecular Polymeric Nanomedicine for Self‐Cascade Amplified Cancer Immunotherapy
Wenting Hu, Binglin Ye, Guocan Yu, et al.
Advanced Science (2024) Vol. 11, Iss. 20
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top